Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial crawled date : 2021 - 10 - 14 save search
First Wave BioPharma Announces Dosing of First Patient in Phase 2b Clinical Trial Evaluating Topical Niclosamide in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis
Published: 2021-10-14 (Crawled : 23:00) - biospace.com/
FWBI | $2.59 -8.8% -9.65% 83K
|
Manufacturing
|
| O: -1.01%
H: 0.0%
C: -2.38%
phase 2 biopharma phase 2b trial
MSC Industrial Supply Co. Declares Regular Quarterly Dividend
Published: 2021-10-14 (Crawled : 21:00) - prnewswire.com
MSM | $92.46 1.12% 0.0% 560K
|
Distribution Services
|
| O: 0.78%
H: 0.0%
C: -1.6%
trial
Lilly Announces Updated Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Presented at ESMO Virtual Plenary and Simultaneously Published in the Annals of Oncology
Published: 2021-10-14 (Crawled : 19:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.24%
H: 0.6%
C: -0.14%
phase 3 trial
Hoag First Hospital in Orange County to Enroll Patients in NK Cell Therapy Clinical Trial for Triple-Negative Breast Cancer Patients
Published: 2021-10-14 (Crawled : 18:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
therapy cancer breast cancer trial enroll
With Market Size Valued at $185.2 Billion by 2026, it's a Healthy Outlook for the Global Industrial Communication Market
Published: 2021-10-14 (Crawled : 16:00) - prnewswire.com
SBGSF | $230.0 0.82% 3.2K
|
Producer Manufacturing
|
| O: 2.32%
H: 2.01%
C: 2.01%
SBGSY | $45.56 -1.39% 170K
|
Manufacturing
|
| O: 1.72%
H: 0.97%
C: 0.76%
GIC | $40.52 0.87% 0.0% 56K
|
Retail Trade
|
| O: 1.27%
H: 1.89%
C: 1.3%
ROK | $269.96 -1.29% 0.0% 1.2M
|
Producer Manufacturing
|
| O: 0.81%
H: 2.65%
C: 2.61%
ERIC | News | $5.1 0.79% 0.78% 19M
|
Electronic Technology
|
| O: 0.58%
H: 0.03%
C: -0.75%
CSCO | $48.33 0.46% 0.46% 20M
|
Technology Services
|
| O: 0.86%
H: 1.38%
C: 1.02%
communication trial
Industrial Transmitters Market size to grow by USD 4.70 bn from 2021 to 2025 | ABB Ltd. and AMETEK Inc. among key market contributors | Technavio
Published: 2021-10-14 (Crawled : 15:15) - prnewswire.com
ABLZF | News | $48.065 -32.74% 4.7K
|
Producer Manufacturing
|
| O: 2.38%
H: 2.15%
C: 2.15%
HON | News M | $194.27 1.67% 1.64% 3.6M
|
Producer Manufacturing
|
| O: 0.73%
H: 0.75%
C: 0.66%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: 1.21%
H: 0.94%
C: 0.85%
trial
MAIA Biotechnology, Inc. Announces $6.2 Million Financing to Advance Targeted Immuno-Oncology Studies
Published: 2021-10-14 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.2%
H: 0.08%
C: -0.43%
biotech technology iot
Exelixis In-Licenses Second Anti-Cancer Compound from Aurigene Following FDA Acceptance of Investigational New Drug Application for Phase 1 Clinical Trial in Non-Hodgkin’s Lymphoma
Published: 2021-10-14 (Crawled : 13:00) - biospace.com/
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: 0.91%
H: 0.99%
C: 0.9%
new drug fda fda acceptance phase 1 cancer drug license trial
Survey Finds Industry Taking Action to Address Challenges from Rapid Move to Decentralized Trials Amid COVID-19
Published: 2021-10-14 (Crawled : 12:15) - prnewswire.com
VEEV | $198.38 -0.58% 0.0% 730K
|
Technology Services
|
| O: 1.41%
H: 2.41%
C: 1.67%
covid trials trial
Elevation Oncology's Seribantumab Included as Part of a Case Series Presentation at the Australasian Gastro-Intestinal Trials Group 2021 Annual Scientific Meeting
Published: 2021-10-14 (Crawled : 12:15) - biospace.com/
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 1.04%
C: -5.13%
presentation test trials trial
Phase 2 Clinical Trial Data of NurOwn® in Progressive MS Will Be Presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
Published: 2021-10-14 (Crawled : 12:15) - biospace.com/
BCLI A | $0.5384 4.69% 4.48% 1M
|
Health Technology
|
| O: 3.17%
H: 0.0%
C: -3.38%
multiple sclerosis treatment phase 2 europe sclerosis research trial
VistaGen Therapeutics Expands Clinical Development of PH94B with Initiation of Phase 2A Trial in Adjustment Disorder
Published: 2021-10-14 (Crawled : 12:15) - globenewswire.com
VTGN | $4.77 1.49% 1.47% 150K
|
Health Technology
|
| O: 0.8%
H: 1.59%
C: -0.4%
phase 2 trial phase 2b ph94
Oncolytics Biotech®Partner Adlai Nortye Doses First Patient in Chinese Bridging Trial Evaluating Pelareorep-Paclitaxel Combination Treatment in Breast Cancer
Published: 2021-10-14 (Crawled : 12:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 1.42%
H: 3.26%
C: 1.86%
chinese treatment cancer biotech iot breast cancer trial
First Patient Enrolled in U.S. STAR-T Pivotal Trial Evaluating the DrugSorb-ATR™ Antithrombotic Removal System to Remove Ticagrelor During Cardiothoracic Surgery
Published: 2021-10-14 (Crawled : 11:00) - prnewswire.com
CTSO | $0.8026 0.2% 0.2% 46K
|
Health Technology
|
| O: 0.33%
H: 0.49%
C: -2.6%
drug iot cardio trial enroll
Journal of Infectious Diseases and Treatment Publishes Positive Trial Data of Aviptadil in High Comorbidity Patients Suffering from Critical COVID-19 with Respiratory Failure
Published: 2021-10-14 (Crawled : 11:00) - prnewswire.com
NRXP 2 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 27.44%
H: 12.14%
C: -1.0%
covid disease treatment infectious disease positive respiratory trial aviptadil
Neurology Clinical Trials Market Size Worth $7.4 Billion By 2028: Grand View Research, Inc.
Published: 2021-10-14 (Crawled : 09:00) - prnewswire.com
ICLR | $288.32 -1.2% -1.21% 640K
|
Health Technology
|
| O: 0.84%
H: 1.56%
C: 0.97%
clinical trials trials research trial
Industrial Welding Robots Market Size to grow by USD 2.30 Bn from 2021 to 2025 |17000+ Technavio Reports
Published: 2021-10-14 (Crawled : 06:00) - prnewswire.com
ABLZF | News | $48.065 -32.74% 4.7K
|
Producer Manufacturing
|
| O: 2.38%
H: 2.15%
C: 2.15%
DNZOY | $18.47 0.08% 47K
|
Manufacturing
|
| O: 4.23%
H: 0.0%
C: -3.07%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: 1.21%
H: 0.94%
C: 0.85%
trial
Cutting Tool Inserts Market to grow at a CAGR of 6% | Witnesses Emergence of Asahi Diamond Industrial Co. Ltd. and Ceratizit SA Among Key Players | 17000 + Technavio Reports
Published: 2021-10-14 (Crawled : 06:00) - prnewswire.com
KMT | $24.51 1.7% 0.0% 660K
|
Producer Manufacturing
|
| O: 1.4%
H: 3.13%
C: 2.88%
trial merge
Adocia’s partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispro Phase 3 Trial to Treat Type 1 and Type 2 Diabetes in China
Published: 2021-10-14 (Crawled : 06:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.24%
H: 0.6%
C: -0.14%
diabetes china insulin phase 3 trial clearance
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
JBI 4 | $15.14 1.34% 0.0% 2.9M
|
SBS | $15.49 -1.59% -0.84% 4.6M
|
Utilities
ML 4 | $69.13 -4.48% -1.64% 110K
|
SG 4 | $20.65 -0.91% -2.14% 1.4M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.